Breaking News
April 20, 2018 - College students with autism have high rate of suicidal thoughts
April 20, 2018 - Study sheds light on how the HSC niche is maintained
April 20, 2018 - Drug test spurs frank talk between hypertension patients and doctors
April 19, 2018 - Low-cost deworming drug improves female farmers’ physical fitness
April 19, 2018 - Genome editing identifies neural circuit behind leptin’s anti-obesity and anti-diabetes effects
April 19, 2018 - Many European countries lack comprehensive policy to eliminate viral hepatitis
April 19, 2018 - Young people with ADHD ‘more likely’ to come from deprived neighbourhoods
April 19, 2018 - SLU professor discovers new biomarkers for chlorine gas exposure
April 19, 2018 - Study proposes new mechanism that may contribute to gender differences in weight control
April 19, 2018 - Sleep restriction therapy does not interfere with insomnia patient’s driving ability, research shows
April 19, 2018 - Deep brain stimulation offers relief to UTHealth patient with treatment-resistant depression
April 19, 2018 - Study shows fatty fish and camelina oil boost HDL and IDL cholesterol
April 19, 2018 - FDA Alert: Euphoric Capsules by Epic Products: Recall
April 19, 2018 - Researchers identify peptide produced during cartilage deterioration as a potential source of osteoarthritis pain
April 19, 2018 - New breakthrough may allow scientists to orchestrate tissue regeneration in humans
April 19, 2018 - SYGNIS AG introduces new TruePrime apoptotic cell free DNA amplification kit
April 19, 2018 - Innovative device shows promise in capturing and releasing circulating tumor cells
April 19, 2018 - Researchers shed light on role of striosomal neurons in reinforcement learning
April 19, 2018 - Genetic make-up impacts long-term effectiveness of phobia treatment
April 19, 2018 - Novel biomarker can distinguish malignant lung nodules
April 19, 2018 - Study reports promising novel approach to treat therapy resistant pediatric brain tumors
April 19, 2018 - One-Hour Plasma Glucose Useful Predictor of Diabetic Retinopathy
April 19, 2018 - Hydroxychloroquine no more effective than placebo for relieving osteoarthritis hand pain
April 19, 2018 - Transplanted livers have a protective effect and reduce potential for organ rejection
April 19, 2018 - Researchers develop new method to study activity of inflammatory cells
April 19, 2018 - Researchers discover highly antibiotic resistant superbugs in Gulf States
April 19, 2018 - Interaction between dioxin and HLA gene variant activates events associated with rheumatoid arthritis
April 19, 2018 - Eyes of adolescents could be associated with increased risk of cardiovascular disease in later life
April 19, 2018 - U.S. Women Less Likely Than Men to Get Statins After Heart Attack
April 19, 2018 - Health Canada grants cannabis cultivation license to High Park Farms
April 19, 2018 - Atypical brain development observed in preschoolers with ADHD symptoms
April 19, 2018 - SC Johnson releases annual Sustainability Report
April 19, 2018 - Positive attitudes about aging reduce risk of dementia in older adults
April 19, 2018 - Environmental pollutants found to worsen rheumatoid arthritis
April 19, 2018 - UT Southwestern scientists discover protein linked to metastatic breast cancer
April 19, 2018 - Study highlights need for further evidence to improve symptom management in end of life care
April 19, 2018 - Detecting diminished dopamine-firing cells inside brain could reveal earliest signs of Alzheimer’s
April 19, 2018 - Uniqsis offers high-power LED light unit for scalable flow photochemistry reactions
April 19, 2018 - Case study shows how intravascular ultrasound imaging helps detect acute aortic syndrome
April 19, 2018 - Research reveals new mechanism by which HIV evades the immune system
April 19, 2018 - Nanodisc-delivered cancer treatment helps eliminate tumors
April 19, 2018 - Functional connectivity MRI could help detect brain disorders and diseases
April 19, 2018 - Finding better way to quantify neuropathy symptoms and treatment efficacy
April 19, 2018 - Study examines effectiveness of caregiver education about sickle cell trait
April 19, 2018 - High-resolution images of tumor vasculature using new technology
April 19, 2018 - Lack of sleep may be linked to risk factor for Alzheimer’s disease
April 19, 2018 - Study finds neurotransmitter may play a role in alcohol relapse, addiction
April 19, 2018 - Researchers build molecular networks of calcific aortic valve disease
April 19, 2018 - Researchers develop highly specific apoptosis assay for pharmacodynamic analyses of tumor specimens
April 19, 2018 - Scientists decipher mechanism of chemotherapy induced female infertility
April 19, 2018 - New insight may allow researchers to design drugs that improve immune responses to vaccines
April 19, 2018 - FDA Approves Crysvita (burosumab-twza) for X-Linked Hypophosphatemia
April 19, 2018 - Researchers uncover origin of virus-fighting plasma B cells
April 19, 2018 - Study finds no evidence of lower intelligence in young children who had anesthesia
April 19, 2018 - Baboons break out of research facility briefly
April 19, 2018 - Study shows how deployment time increases risk of suicide attempt in soldiers
April 19, 2018 - Specific odors from malaria infected individuals attract more mosquitoes
April 19, 2018 - FDA Alert: Rhino 69 Extreme 50000 by AMA Wholesale: Recall
April 19, 2018 - Top HIV cure research team refutes major recent results on how to identify HIV persistence
April 19, 2018 - Experts propose new solutions to increase benefit, affordability of targeted cancer medicines
April 19, 2018 - Deficiency of innate immune adaptor TRIF shortens survival time of ALS mice
April 19, 2018 - New machine learning method offers better way to detect heart disease
April 19, 2018 - CNIO researchers determine structure of protein complex related to cell survival
April 19, 2018 - Faith-based diabetes support program launched by UTSA research team
April 19, 2018 - Volumetric Laser Endomicroscopy Helps ID Barrett’s Regions
April 19, 2018 - Engineered cartilage template to heal broken bones
April 19, 2018 - New computational framework accurately predicts drug-drug and drug-food interactions
April 18, 2018 - Some human cancers may be result of evolutionary accidents, research finds
April 18, 2018 - Higher levels of education linked to lower dementia risk in older African Americans
April 18, 2018 - Smoking Puts Blacks at Higher Risk for Heart Failure
April 18, 2018 - Physiotherapist contributes to guidelines for knee cartilage treatment
April 18, 2018 - Researchers use ‘top-down proteomics’ strategy to get new insights into cancer
April 18, 2018 - Physician assistants less likely to accurately diagnose early stage skin cancers
April 18, 2018 - New faster, streamlined method for bowel cancer detection and treatment
April 18, 2018 - Researchers identify new Listeria species in Costa Rica
April 18, 2018 - Novel interactive diagram shows many facets of mild traumatic brain injury
April 18, 2018 - Short sleep linked to obesity in children and adolescents
April 18, 2018 - When weight loss helps with sleep
April 18, 2018 - New mathematical model can predict efficiency of microbiome therapies
April 18, 2018 - People with high LDL cholesterol levels likely to get greater benefits from statins
Vaccines in the Aging Population

Vaccines in the Aging Population

image_pdfDownload PDFimage_print

An interview with Reda Guiha, Regional President, International Developed Markets Pfizer Vaccines, conducted by Alina Shrourou, BSc

Why are we discussing vaccines in the aging population?

The World Health Organisation marked World Pneumonia Day on November 12th to promote interventions to protect against, prevent and treat pneumonia. The condition is a worldwide killer affecting people of all ages, however the ‘aging population’ is at an increased risk.

Streptococcus pneumoniae. Credit: Maxx-Studio/Shutterstock.com

A recent analysis titled PneuVUE® 65 years and over report revealed that only 18% of people aged 65 and over report having received a pneumonia vaccination. An unacceptable statistic considering pneumonia causes over 100,000 deaths per year in the 65 years and over age group in Europe.

What do you mean by the term aging population?

The term refers to the increasing proportion and number of older persons, typically aged 60 years and over. It is estimated that between 2000 and 2050, the proportion of the world’s population over 60 years old will double from about 11% to 22%.

Improvements in public health, nutrition and medicine mean people are living longer than ever before. Every country is experiencing growth of this kind and, according to the United Nations, aging will become one of the most significant social transformations of the twenty-first century – with implications for nearly all sectors of society. Europe and Japan in particular will be significantly affected by this huge demographic shift, which will pose challenges for healthcare systems.

What challenges does the aging population pose on healthcare as we know it?

Demand for healthcare will increase across primary and secondary care, with long-term support placing massive pressure on healthcare systems. Research has shown that older adults who adopt healthy behaviors and use preventive services – like vaccinations – are more likely to remain healthy, live independently, and incur fewer health-related costs.

Despite this, healthcare systems are geared towards diagnosis and treatment, with European governments spending an average of just 2.8% on healthcare prevention. The inevitability of challenges associated with an aging population means that healthcare communities should shift the balance from treating infectious diseases, such as pneumonia and influenza, to preventing them.

Why are there low numbers of older people reporting vaccination?

Even in healthcare systems where vaccines are readily available to older people, vaccination rates remain suboptimal. We need to understand why people from 65-year-olds running companies, to 75-year-olds juggling the care of grandchildren, or 85-year-olds living in care homes, are falling through the system when it comes to vaccines.

The latest PneuVUE® analysis confirms a need for improved vaccination awareness in this population and reveals that only 35% of adults aged 65 and over know that a pneumonia vaccination exists. Low awareness of pneumonia, its severity and preventative options are key reasons for why a ‘vaccination gap’ in this population has emerged.

Is it important for this gap to be closed? If so, what is being done to encourage people to get vaccines?

The World Health Organization in Europe recognizes vaccination as one of the health strategies with the greatest potential to achieve health gains for older people. As we work together to manage the challenges associated with the aging demographic of our world’s population, closing the ‘vaccination gap’ in older people should be a priority for healthcare systems.

At Pfizer, we have supported a number of initiatives of international NGOs, to raise awareness of the importance of healthy aging and the vital role that vaccination can play. Wherever possible, public dialogue around vaccination should be encouraged, and if you know an elderly person who does not receive vaccination against infectious diseases, you can suggest they visit their doctor to discuss whether this option is right for them. Only through healthcare communities working together, can we start to close the ‘vaccination gap’.

Are there other benefits associated with closing the vaccination gap?

New strategies are urgently required to combat threats such the growing antimicrobial resistance crisis. It is a growing opinion that better vaccine coverage in older people is part of the comprehensive approach needed to tackle antimicrobial resistance. Vaccines can help address this global concern by preventing infections as well as reducing the transmission and circulation of antibiotic-resistant strains of bacteria.

How large is the threat of antimicrobial resistant in older people?

Antimicrobial resistance is an urgent and growing global health threat. With antibiotics prescribed more frequently to older adults than to younger patients, the aging population will drive even greater antibiotic consumption worldwide.

Furthermore, long-term care facilities that house older adults can become ‘reservoirs of resistance’ due to high levels of medication use in such facilities. Antibiotic-resistant infections are already resulting in over 50,000 deaths annually in Europe and the associated economic burden is estimated to be €1.5 billion, per year. If the issue of antimicrobial resistance is not rapidly addressed, estimates indicate that by 2050 more people will die from antibiotic-resistant infections than cancer.

How can the healthcare industry help address these challenges?

Industry partners, healthcare providers and governments need to collaborate to secure additional investment and encourage innovation to address critical challenges such as the vaccination gap and antimicrobial resistance.

At Pfizer, we have recently collaborated with the British Society for Antimicrobial Chemotherapy and the University of Dundee to launch the Massive Open Online Course on antimicrobial stewardship. The course helps healthcare professionals understand and address the global threat of antimicrobial resistance, focusing on how to responsibly use high-quality antibiotics safely in everyday practice. So far, over 5,000 healthcare professionals have completed the course.

Pfizer’s current and pipeline vaccines offer potential to tip the balance for healthcare systems from treatment to prevention. Through industry collaborations and global initiatives, Pfizer is not only helping to keep older people healthier for longer, but also improving the wellbeing of the population. Vaccination strategies are key to help in the fight against challenges such as the antimicrobial resistance crisis.

Where can readers find more information?

For more information please have a look at our website: https://www.pfizer.com/science/vaccines

And for the PneuVUE® 65 years and over report: https://www.ipsos.com/ipsos-mori/en-uk/pneuvuer-new-view-pneumonia-among-older-adults

About Reda Guiha

Reda Guiha is the Regional President of the Vaccines Division, International Developed Markets for Pfizer Inc., one of the world’s premier innovative biopharmaceutical companies. Reda has held senior international sales and marketing roles across a number of major disease areas in different countries and regions.

In 2000, Reda joined Pharmacia’s French affiliate as Oncology Business Unit Director and managed the Specialty Therapeutics Business Unit in France following Pharmacia’s merger with Pfizer in 2003. In 2006, he was appointed Senior Sales Director for the Cardiology Franchise and, in 2007, became Vice President for the Oncology, Ophthalmology and Endocrinology Division.

Reda then managed the French Oncology Business Unit until September 2012 when he progressed to Business Unit Head of Specialty Care, France; a division responsible for vaccines, inflammation and hospital specialty products. After this national tenure, Reda was appointed Regional President of the European Vaccine Business in 2014 and then Regional President of the Vaccines Division in 2016 when his role was expanded to include Japan, Korea, Australia and New Zealand.

Prior to joining Pharmacia and Pfizer, Reda worked for Rhone-Poulenc Rorer (Aventis) as Senior International Marketing Director for Oncology and later as Vice President of Oncology based in France and the United States. He originally trained as a pharmacist before joining the pharmaceutical industry as a medical sales representative in Egypt, the United Kingdom and Italy.

Tagged with:

About author

Related Articles